Table 9.
Study Location | Insomnia/Otherwise Healthy Individuals | Autism | Atopic Dermatitis | ADHD | Neurodevelopmental Disorders |
---|---|---|---|---|---|
United States | 0 | 4* | 0 | 0 | 1 |
Canada | 1 | 0 | 0 | 1 | 2 |
European Union | 6 | 2* | 0 | 2 | 2 |
Non-European Union (such as Norway) | 1 | 0 | 0 | 0 | 0 |
United Kingdom | 1 | 2 | 0 | 0 | 3 |
Taiwan | 0 | 0 | 1 | 0 | 0 |
ADHD, attention-deficit/hyperactivity disorder
* One study consisted of United States and 10 European Union sites.